At GYNOAID – ARTIFICIAL INTELLIGENCE DEVELOPMENT, we are dedicated to transforming women’s health with cutting-edge AI solutions in Gynecology. We are thrilled to announce the publication of our latest study, “Artificial Intelligence and Colposcopy: Automatic Identification of Cervical Squamous Cell Carcinoma Precursors,” in the prestigious Journal of Clinical Medicine (JCM) MDPI Medicine (Q1 Medicine).

Our team has developed an innovative AI model to identify cervical cancer precursors during colposcopy with 99.0% accuracy. We recognize the invaluable support of our partners at Centro Materno e Infantil do Norte in achieving this breakthrough. GYNOAID – ARTIFICIAL INTELLIGENCE DEVELOPMENT aims to revolutionize colposcopy, enhancing the diagnosis of HPV-related cancers and improving women’s health outcomes.